Literature DB >> 23365176

Congenital familial myasthenic syndromes: disease and course in an affected dizygotic twin pair.

Piero Pavone1, Andrea Domenico Praticò, Vito Pavone, Raffaele Falsaperla.   

Abstract

The present report describes clinical variability in an affected dizygotic twin pair. Twin 1 showed classical features of the congenital myasthenic syndromes (CMS), that is, ptosis, dysphonia, asthenia and hypotonia. In twin 2, these clinical signs were less pronounced, but subtle resulting in severe lumbar hyperlordosis. Molecular analysis, performed for both twins, revealed the presence of three polymorphisms in the heterozygous form in RAPSN gene. The present report highlights the clinical variability of the CMS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23365176      PMCID: PMC3603822          DOI: 10.1136/bcr-2012-007651

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

Review 1.  Current understanding of congenital myasthenic syndromes.

Authors:  Andrew G Engel; Steven M Sine
Journal:  Curr Opin Pharmacol       Date:  2005-06       Impact factor: 5.547

2.  Multiexon deletions account for 15% of congenital myasthenic syndromes with RAPSN mutations after negative DNA sequencing.

Authors:  Karen Gaudon; Isabelle Pénisson-Besnier; Brigitte Chabrol; Françoise Bouhour; Laurence Demay; Asma Ben Ammar; Stéphanie Bauché; Christophe Vial; Guillaume Nicolas; Bruno Eymard; Daniel Hantaï; Pascale Richard
Journal:  J Med Genet       Date:  2010-10-07       Impact factor: 6.318

3.  Electromyography (EMG) accuracy compared to muscle biopsy in childhood.

Authors:  Malcolm Rabie; Joseph Jossiphov; Yoram Nevo
Journal:  J Child Neurol       Date:  2007-07       Impact factor: 1.987

4.  Congenital myopathy with myasthenic features and congenital cataract in two siblings.

Authors:  Y Nishida; T Kobayashi; M Machi; T Yamada; T Kitaguchi; K Oda; I Goto
Journal:  J Neurol       Date:  1989-03       Impact factor: 4.849

5.  Congenital myasthenic syndrome: presentation, electrodiagnosis, and muscle biopsy.

Authors:  Christina A Gurnett; Judy A Bodnar; Jeffrey Neil; Anne M Connolly
Journal:  J Child Neurol       Date:  2004-03       Impact factor: 1.987

6.  Myasthenic syndrome due to defects in rapsyn: Clinical and molecular findings in 39 patients.

Authors:  M Milone; X M Shen; D Selcen; K Ohno; J Brengman; S T Iannaccone; C M Harper; A G Engel
Journal:  Neurology       Date:  2009-07-21       Impact factor: 9.910

Review 7.  Neurophysiological strategies for the diagnosis of disorders of the neuromuscular junction in children.

Authors:  Matthew Pitt
Journal:  Dev Med Child Neurol       Date:  2008-02-28       Impact factor: 5.449

8.  Rapsyn N88K is a frequent cause of congenital myasthenic syndromes in European patients.

Authors:  J S Müller; G Mildner; W Müller-Felber; U Schara; K Krampfl; B Petersen; S Petrova; R Stucka; W Mortier; J Bufler; G Kurlemann; A Huebner; L Merlini; H Lochmüller; A Abicht
Journal:  Neurology       Date:  2003-06-10       Impact factor: 9.910

9.  Lack of association between acetylcholine receptor epsilon polymorphisms and early-onset myasthenia gravis.

Authors:  Domenico Marco Bonifati; Nick Willcox; Angela Vincent; David Beeson
Journal:  Muscle Nerve       Date:  2004-03       Impact factor: 3.217

  9 in total
  1 in total

1.  Congenital myasthenic syndromes.

Authors:  Josef Finsterer
Journal:  Orphanet J Rare Dis       Date:  2019-02-26       Impact factor: 4.123

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.